カタログ製品コード : C-EK133HS
Human IL-33 High Sensitivity ELISA kit
24T | ¥64,900 | (¥2,704/T) (税別) |
48T | ¥81,600 | (¥1,700/T) (税別) |
96T | ¥93,000 | (¥969/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK133HS
Human IL-33 High Sensitivity ELISA kit
24T | ¥64,900 | (¥2,704/T) (税別) |
48T | ¥81,600 | (¥1,700/T) (税別) |
96T | ¥93,000 | (¥969/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | IL-33 | Human | 6.25 - 400 pg/ml | 20 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against IL-33 |
Human IL-33 Standard, lyophilized |
IL-33 Detect Antibody |
Standard Diluent |
Streptavidin-HRP |
Amplification Reagent Concentrate |
Amplification Diluent |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,Interleukin-33,IL-33,Interleukin-1 family member 11,IL-1F11,Nuclear factor from high endothelial venules,NF-HEV,IL33,C9orf26,IL1F11,NFHEV
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection ofhuman IL-33. The Human IL-33 High Sensitivity ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Interleukin 33 (IL-33), also known as NF-HEV and DVS 27, is a 30-kDa member of the IL-1 family produced by a wide variety of cell types, including fibroblasts, mast cells, dendritic cells, macrophages, osteoblasts, endothelial cells, and epithelial cells. IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines. IL-33 mediates its biological effects by interacting with the receptors ST2 and IL-1 Receptor Accessory Protein (IL1RAP), activating intracellular molecules in the NF-κB and MAP kinase signaling pathways that drive production of type 2 cytokines (e.g. IL-5 and IL-13) from polarized Th2 cells. The induction of type 2 cytokines by IL-33 in vivo is believed to induce the severe pathological changes observed in mucosal organs following administration of IL-33.